SSA
CTOR

Schonfeld Strategic Advisors’s Citius Oncology CTOR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,600
Closed -$131K – 2564
2023
Q1 		$131K Buy
+12,600
New +$129K ﹤0.01% 1639

Other funds holding CTOR

KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Schonfeld Strategic Advisors's CTOR Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of Citius Oncology (CTOR) in Q2 2023, closing a stake of 12,600 shares — an estimated $131K sold.

Schonfeld Strategic Advisors first reported a position in CTOR in Q1 2023 and held it in 1 quarter. The position peaked at $131K in Q1 2023. 22 funds tracked by Wall St. Rank hold CTOR as of Q2 2023.

  • Schonfeld Strategic Advisors reported no remaining Citius Oncology position as of Q2 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 12,600 Citius Oncology shares in Q2 2023, an estimated $131K.
  • Schonfeld Strategic Advisors first reported a position in Citius Oncology in Q1 2023 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Citius Oncology position peaked at $131K in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.